Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Version history shows updates to Study Status and Recruitment Status, including changes to Contacts/Locations. These updates reflect changes in the trial's current activity and site information.
    Difference
    0.1%
    Check dated 2025-11-03T20:42:02.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    13%
    Check dated 2025-10-06T04:50:54.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T02:55:48.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The Back to Top element was removed as a secondary UI change; no significant core content changes are indicated.
    Difference
    0.8%
    Check dated 2025-09-14T18:52:48.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.8%
    Check dated 2025-09-07T13:35:02.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific study status contacts, while removing various location-related terms and details.
    Difference
    8%
    Check dated 2025-08-31T11:34:10.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.